Discoloration of intraocular lens subsequent to rifabutin use.
Jones
Daniel Fuller
DF
Division of Ophthalmology, Fletcher Allen Health Care, UHC Fourth Floor, Burlington, VT 05405.
Irwin
Alan Emory
AE
D000904:Antibiotics, Antitubercular / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007910:Lenses, Intraocular; D008875:Middle Aged; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy; D010859:Pigmentation Disorders / Q000139:chemically induced*; D017828:Rifabutin / Q000009:adverse effects* / Q000627:therapeutic use; D012826:Silicone Elastomers
D000904:Antibiotics, Antitubercular; D012826:Silicone Elastomers; D017828:Rifabutin